News-Medical.Net November 25, 2024
Wiley

Researchers address increasing rates of cancer incidence and mortality in developing countries, and challenges in accessing treatments.

A recent analysis reveals striking disparities in the cost and availability of cancer drugs across different regions of the globe, with significant gaps between high- and low-income countries. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.

The analysis, which drew on relevant published studies and reviews related to cancer and the availability of cancer treatments, predicts that there will be an estimated 28.4 million new cancer cases worldwide in 2040 alone. In the coming years, cancer incidence is expected to increase most significantly in low-income countries. Cancer mortality rates are also increasing in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Patient / Consumer, Provider, Survey / Study, Trends
Early hospice care has transformative impact
STAT+: UnitedHealth pays its own physician groups considerably more than others, driving up consumer costs and its profits
California Sets 15% Goal for Primary Care Spending by 2034
AI Robot Scanner as Good as Rheumatologists at Assessing RA
Hospitals continue to struggle with adverse events, medical errors

Share This Article